CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating activities:
Net income	$ 26,231	$ 33,355
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Amortization of deferred financing costs	4,058	4,491
Accretion of deferred loan origination fees and costs	(4,938)	(3,911)
Stock-based compensation	1,465	1,018
Depreciation of real estate owned	0	449
Provision for current expected credit losses	7,174	(7,123)
Amortization of derivative financial instruments	(253)	0
Gain on sale of real estate owned	(2,197)	0
Changes in operating assets and liabilities:
Other assets	(1,930)	(9,346)
Due to affiliate	406	581
Other liabilities	(864)	267
Net cash provided by (used in) operating activities	29,152	19,781
Investing activities:
Issuance of and fundings on loans held for investment	(523,735)	(463,871)
Principal repayment of loans held for investment	400,429	155,302
Receipt of origination fees	6,794	1,342
Proceeds from sale of real estate owned	38,227	(26)
Payments under derivative financial instruments	2,085	(700)
Net cash provided by (used in) investing activities	(76,200)	(307,953)
Financing activities:
Proceeds from notes payable	0	9,695
Repayments of notes payable	(51,110)	(27,880)
Payment of secured funding costs	(1,663)	(9,133)
Proceeds from issuance of debt of consolidated VIEs	0	540,471
Repayments of debt of consolidated VIEs	(11,000)	0
Dividends paid	(33,414)	(25,373)
Proceeds from sale of common stock	106,267	202,660
Payment of offering costs	(34)	(26)
Net cash provided by (used in) financing activities	22,058	289,067
Change in cash and cash equivalents	(24,990)	895
Cash and cash equivalents, beginning of period	50,615	74,776
Cash and cash equivalents, end of period	25,625	75,671
Secured funding agreements
Financing activities:
Proceeds from secured funding agreements	225,192	207,237
Repayments of secured funding agreements	(212,180)	(558,584)
Secured term loan
Financing activities:
Repayments of secured funding agreements	$ 0	$ (50,000)